glutathione disulphide
Recently Published Documents


TOTAL DOCUMENTS

26
(FIVE YEARS 3)

H-INDEX

15
(FIVE YEARS 1)

2021 ◽  
Vol 83 ◽  
pp. 104479
Author(s):  
Teresa Del Castillo-Santaella ◽  
Juan José Hernández-Morante ◽  
Jesús Suárez-Olmos ◽  
Julia Maldonado-Valderrama ◽  
Jorge Peña-García ◽  
...  

2017 ◽  
Vol 112 ◽  
pp. 360-375 ◽  
Author(s):  
Daniela Giustarini ◽  
Graziano Colombo ◽  
Maria Lisa Garavaglia ◽  
Emanuela Astori ◽  
Nicola Marcello Portinaro ◽  
...  

2017 ◽  
Vol 7 (1) ◽  
Author(s):  
Christina Klinkhammer ◽  
Christof Verlackt ◽  
Dariusz śmiłowicz ◽  
Friederike Kogelheide ◽  
Annemie Bogaerts ◽  
...  

2017 ◽  
Vol 37 ◽  
pp. 650-657
Author(s):  
Florian Lehnhardt ◽  
Dong Liang ◽  
Qimin Chen ◽  
Restituto Tocmo ◽  
Michael Rychlik ◽  
...  

2013 ◽  
Vol 2013 ◽  
pp. 1-10 ◽  
Author(s):  
Nicola Traverso ◽  
Roberta Ricciarelli ◽  
Mariapaola Nitti ◽  
Barbara Marengo ◽  
Anna Lisa Furfaro ◽  
...  

Glutathione (GSH) plays an important role in a multitude of cellular processes, including cell differentiation, proliferation, and apoptosis, and disturbances in GSH homeostasis are involved in the etiology and progression of many human diseases including cancer. While GSH deficiency, or a decrease in the GSH/glutathione disulphide (GSSG) ratio, leads to an increased susceptibility to oxidative stress implicated in the progression of cancer, elevated GSH levels increase the antioxidant capacity and the resistance to oxidative stress as observed in many cancer cells. The present review highlights the role of GSH and related cytoprotective effects in the susceptibility to carcinogenesis and in the sensitivity of tumors to the cytotoxic effects of anticancer agents.


Sign in / Sign up

Export Citation Format

Share Document